Expectations and experiences of patients, experts and physicians with the term immunotherapy” in cancer
- Conditions
- various cancersC00-C97Malignant neoplasms
- Registration Number
- DRKS00011868
- Lead Sponsor
- niversitätsklinikum Heidelberg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
General inclusion criteria for all members of the cohort:
•Age = 18 Years
•Native German speaker or fluent German speaker
•Written declaration of consent
For patients who received immunotherapy:
•The patient is being treated with immunotherapy at the moment or was treated within the last year
For patients who received chemotherapy:
•The patient is being treated with chemotherapy at the moment or was treated within the last year
•The patient has no personal experience with immunotherapy
For patient who do not have cancer:
•The patients never had cancer
•Also their marriage partners, life partners and children never had cancer
•They do not work in a medical profession
For physicians:
•The exercise of their profession is connected to direct patient contact as well as cancer therapies. In the past they had talks with patients about immunotherapy and chemotherapy.
For staff members of cancer information services:
•They had to deal with patient inquiries regarding immunotherapy, and give information about this topic
•Limited capacity to contract
•Current cognitive reduction
•Serious psychiatric diseases or the existence of a somatization disorder, a general anxiety disorder or a serious depression
•Emotional stress
•Pregnancy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessement of expectations and experiencies of patients, experts and physicians concerning cancer immunotherapy and chemotherapy with interviews and questionnaires
- Secondary Outcome Measures
Name Time Method Comparison between immunotherapy and chemotherapy.